Epinephrine drives human M2a allergic macrophages to a regulatory phenotype reducing mast cell degranulation in vitro

Jelena Gotovina; Rodolfo Bianchini; Judit Fazekas-Singer; Ina Herrmann; Giulia Pellizzari; Ian D. Haidl; Karin Hufnagl; Sophia N. Karagiannis; Jean S. Marshall; Erika Jensen-Jarolim

doi:10.1111/all.14299

Epinephrine drives human M2a allergic macrophages to a regulatory phenotype reducing mast cell degranulation in vitro

Jelena Gotovina, Rodolfo Bianchini, Judit Fazekas-Singer, Ina Herrmann, Giulia Pellizzari, Ian D. Haidl, Karin Hufnagl, Sophia N. Karagiannis, Jean S. Marshall, Erika Jensen-Jarolim

科研成果: 期刊稿件 › 快报 › 同行评审

5 引用（Scopus）

源语言	英语
页（从-至）	2939-2942
页数	4
期刊	Allergy: European Journal of Allergy and Clinical Immunology
卷	75
期	11
DOI	https://doi.org/10.1111/all.14299
出版状态	已出版 - 11月 1 2020
已对外发布	是

!!!ASJC Scopus Subject Areas

免疫学和过敏症
免疫学

访问文件

10.1111/all.14299

其它文件与链接

引用此

Gotovina, J., Bianchini, R., Fazekas-Singer, J., Herrmann, I., Pellizzari, G., Haidl, I. D., Hufnagl, K., Karagiannis, S. N., Marshall, J. S., & Jensen-Jarolim, E. (2020). Epinephrine drives human M2a allergic macrophages to a regulatory phenotype reducing mast cell degranulation in vitro. Allergy: European Journal of Allergy and Clinical Immunology, 75(11), 2939-2942. https://doi.org/10.1111/all.14299

Gotovina, J, Bianchini, R, Fazekas-Singer, J, Herrmann, I, Pellizzari, G, Haidl, ID, Hufnagl, K, Karagiannis, SN, Marshall, JS & Jensen-Jarolim, E 2020, 'Epinephrine drives human M2a allergic macrophages to a regulatory phenotype reducing mast cell degranulation in vitro', Allergy: European Journal of Allergy and Clinical Immunology, 卷 75, 号码 11, 页码 2939-2942. https://doi.org/10.1111/all.14299

@article{df0e0661d15547cfa544d1af42cc7ea3,

title = "Epinephrine drives human M2a allergic macrophages to a regulatory phenotype reducing mast cell degranulation in vitro",

keywords = "M2a macrophages, allergy, beta2-adrenergic receptor, epinephrine, mast cell",

author = "Jelena Gotovina and Rodolfo Bianchini and Judit Fazekas-Singer and Ina Herrmann and Giulia Pellizzari and Haidl, {Ian D.} and Karin Hufnagl and Karagiannis, {Sophia N.} and Marshall, {Jean S.} and Erika Jensen-Jarolim",

note = "Funding Information: This study was supported by the Austrian Science Fund grants W1205‐B09 (CCHD) and SFB F4606‐B28 to EJJ. The authors acknowledge support by the Medical Research Council (MR/L023091/1) (SNK); the Academy of Medical Sciences (SNK); CR UK//NIHR in England/DoH for Scotland, Wales and Northern Ireland Experimental Cancer Medicine Centre (C10355/A15587) (SNK); Cancer Research UK (C30122/A11527; C30122/A15774) (SNK, GP); and Breast Cancer Now (147), working in partnership with Walk the Walk (SNK). The research was supported by the National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) based at Guy's and St. Thomas' NHS Foundation Trust and King's College London (IS‐BRC‐1215‐20006) (SNK).",

year = "2020",

month = nov,

day = "1",

doi = "10.1111/all.14299",

language = "English",

volume = "75",

pages = "2939--2942",

journal = "Allergy: European Journal of Allergy and Clinical Immunology",

issn = "0105-4538",

publisher = "Wiley-Blackwell",

number = "11",

}

TY - JOUR

T1 - Epinephrine drives human M2a allergic macrophages to a regulatory phenotype reducing mast cell degranulation in vitro

AU - Gotovina, Jelena

AU - Bianchini, Rodolfo

AU - Fazekas-Singer, Judit

AU - Herrmann, Ina

AU - Pellizzari, Giulia

AU - Haidl, Ian D.

AU - Hufnagl, Karin

AU - Karagiannis, Sophia N.

AU - Marshall, Jean S.

AU - Jensen-Jarolim, Erika

N1 - Funding Information: This study was supported by the Austrian Science Fund grants W1205‐B09 (CCHD) and SFB F4606‐B28 to EJJ. The authors acknowledge support by the Medical Research Council (MR/L023091/1) (SNK); the Academy of Medical Sciences (SNK); CR UK//NIHR in England/DoH for Scotland, Wales and Northern Ireland Experimental Cancer Medicine Centre (C10355/A15587) (SNK); Cancer Research UK (C30122/A11527; C30122/A15774) (SNK, GP); and Breast Cancer Now (147), working in partnership with Walk the Walk (SNK). The research was supported by the National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) based at Guy's and St. Thomas' NHS Foundation Trust and King's College London (IS‐BRC‐1215‐20006) (SNK).

PY - 2020/11/1

Y1 - 2020/11/1

KW - M2a macrophages

KW - allergy

KW - beta2-adrenergic receptor

KW - epinephrine

KW - mast cell

UR - http://www.scopus.com/inward/record.url?scp=85083509158&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85083509158&partnerID=8YFLogxK

U2 - 10.1111/all.14299

DO - 10.1111/all.14299

M3 - Letter

C2 - 32246841

AN - SCOPUS:85083509158

SN - 0105-4538

VL - 75

SP - 2939

EP - 2942

JO - Allergy: European Journal of Allergy and Clinical Immunology

JF - Allergy: European Journal of Allergy and Clinical Immunology

IS - 11

ER -